Alexandra Schratter

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data

Shaojie Chen, Helmut Pürerfellner, Christian Meyer et al. · European Heart Journal · 2019 · 153 citations

Invasive versus non-invasive cooling after in- and out-of-hospital cardiac arrest: a randomized trial

Undine Pittl, Alexandra Schratter, Steffen Desch et al. · Clinical Research in Cardiology · 2013 · 78 citations

Cardiopulmonary Resuscitation, Medicine, Patient Safety +7

Catheter Ablation of Ventricular Tachycardia and Mortality in Patients With Nonischemic Dilated Cardiomyopathy

Borislav Dinov, Arash Arya, Alexandra Schratter et al. · Circulation Arrhythmia and Electrophysiology · 2015 · 68 citations · Full text

Adjunctive Left Atrial Posterior Wall Isolation in Treating Atrial Fibrillation

Xi Jiang, Jia Liao, Zhiyu Ling et al. · JACC. Clinical electrophysiology · 2022 · 57 citations

Heart Failure, Cardiac Anaesthesia, Treating Atrial Fibrillation +4